Tenet Healthcare (THC) Receives Media Sentiment Rating of 0.15
Press coverage about Tenet Healthcare (NYSE:THC) has trended somewhat positive recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tenet Healthcare earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.4255226599703 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
- Happy Holidays: GE Plans to Cut 4,500 Jobs in Europe (247wallst.com)
- Richard W. Fisher (marketwatch.com)
- Investors can’t just brush off: State Street Corporation (STT), Tenet Healthcare Corp. (THC) – Market Movers (financialqz.com)
- Huron Valley-Sinai Hospital management calls core of nurse lawsuit a publicity stunt (theoaklandpress.com)
- Guide to Day Traders: Tenet Healthcare Corp (NYSE: THC) – Alpha Beta Stock (alphabetastock.com)
A number of analysts have commented on THC shares. Leerink Swann reiterated an “outperform” rating and issued a $30.00 price objective (up previously from $23.00) on shares of Tenet Healthcare in a research report on Sunday, August 20th. Zacks Investment Research downgraded Tenet Healthcare from a “hold” rating to a “strong sell” rating in a research report on Tuesday, September 19th. Royal Bank Of Canada reiterated a “hold” rating and issued a $25.00 price objective on shares of Tenet Healthcare in a research report on Thursday, August 24th. Robert W. Baird reiterated a “buy” rating and issued a $23.00 price objective on shares of Tenet Healthcare in a research report on Thursday, September 28th. Finally, Citigroup reiterated a “hold” rating and issued a $16.00 price objective on shares of Tenet Healthcare in a research report on Thursday, September 14th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $19.00.
Tenet Healthcare (NYSE:THC) last posted its earnings results on Monday, November 6th. The company reported ($0.17) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.40) by $0.23. The business had revenue of $4.59 billion during the quarter, compared to the consensus estimate of $4.94 billion. Tenet Healthcare had a negative return on equity of 5.61% and a negative net margin of 2.85%. Tenet Healthcare’s revenue was down 5.4% on a year-over-year basis. During the same quarter last year, the company earned $0.16 EPS. sell-side analysts anticipate that Tenet Healthcare will post 0.69 earnings per share for the current fiscal year.
About Tenet Healthcare
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.
Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.